Background: The neonatal intensive care unit (NICU) has high-quality medical staff and tools to care for premature and sick term neonates. Epidemiological information regarding diseases, management and outcome of admitted neonates in NICU are the basis for establishing an effective intervention and adjusting the quality of health care. This study aimed to determine disease patterns, prescribed medications, resource utilization and outcome of the neonates hospitalized in NICU. Methods: Observational cross-sectional study, which included 213 neonates admitted from May 2018 to January 2019, at NICUs of obstetric and children hospitals of Zagazig University. Perinatal and demographic data, diagnosis, prescribed medications and outcome were documented and analyzed. Results: The commonest primary diagnosis during NICU admission were RDS (21.1%) followed by surgical problems (14.6%), late onset sepsis (12.2%), congenital pneumonia (8.5%), early onset sepsis (8%) and aspiration pneumonia (5.2%).All of the studied neonates received antibiotics while (97.1%) received parenteral nutrition ,(30.1%) received positive inotropes and (28.6%) received caffeine citrate. As regard the outcome, (19.2%) of the studied neonates were died and the causes of neonatal deaths were sepsis (12.2%) followed by respiratory failure (5.1%), cardiogenic shock (2.8%), surgical complications (1.9%), inborn error of metabolism (IEM) (1%) and severe hypoxic ischemic encephalopathy (HIE) (0.5%). Conclusion: RDS and surgical diseases were the most common causes of NICU admission. The antibiotics and parenteral nutrition were prescribed frequently in NICU and sepsis was the main cause of newborn mortality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.